M
Mirexus Biotechnologies
Mirexus – Safe & Natural Nanomaterials
About Mirexus Biotechnologies
Mirexus Inc. is a Canadian company specializing in the production of sustainable, plant-derived glycogen known as phytoglycogen, primarily for use in personal care and cosmetics products. This unique ingredient, discovered by researchers at the University of Guelph, is manufactured in Ontario from locally grown feedstock. Mirexus serves clients in the personal care and cosmetics industry, providing them with an innovative ingredient that enhances anti-aging and moisturizing properties in their products. The company operates in the global market, with a particular focus on sustainability and ethical business practices. Mirexus generates revenue by selling its phytoglycogen to manufacturers of skincare and cosmetic products who incorporate it into their formulations. The business model is centered around B2B sales, leveraging its unique product to differentiate itself in a competitive market. Mirexus is committed to minimizing its environmental impact and integrates sustainability into its operations. The company also actively participates in industry events, such as In-Cosmetics Asia, to showcase its products and expand its market reach.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2008
- Headquarters
- Guelph, Canada
- Employees
- 4
- Open positions
- None listed
- Dealroom signal
- 50.3/100
- Industry
- Media, Chemicals
- Sub-industry
- Streaming
- Sector
- Consumer Services, Drones, Spinout, Nanomaterials, DT and LS, science-based
- Technology
- Deep Tech, Nanotech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
Growth signals
Latest recorded traffic for Mirexus Biotechnologies is 1.3K monthly website visits, up 766.7% over the last three months. Mirexus Biotechnologies's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
GreenSky Ventures- GEGoddard Enterprises
Other known investors1 additional known investor
University of Guelph
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Mirexus Biotechnologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Mirexus Biotechnologies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







